5770 |
FATE-MAIN Trial |
Duk-Woo Park |
Apr. 20. 23 |
5769 |
RENOVATE Trial |
Ho Jin Kim |
Apr. 20. 23 |
5768 |
EPIC-CAD Trial |
Min Soo Cho |
Apr. 20. 23 |
5767 |
ASSURE-DES Trial |
Jung-Min Ahn |
Apr. 20. 23 |
5766 |
TAILRORED-CHIP Trial |
Duk-Woo Park |
Apr. 20. 23 |
5765 |
PREVENT Trial |
Seung-Jung Park |
Apr. 20. 23 |
5764 |
OCTIVUS Trial |
Do-Yoon Kang |
Apr. 20. 23 |
5763 |
Anticoagulation vs. Antiplatelet After TAVR: ADAPT-TAVR Trial |
Duk-Woo Park |
Apr. 20. 23 |
5762 |
10-Year Extended Follow-up of BEST Trial |
Jung-Min Ahn |
Apr. 20. 23 |
5761 |
Routine Functional Testing or Standard Care in High-Risk Patients after PCI |
Do-Yoon Kang |
Apr. 20. 23 |